Skip to main content

29-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: Perioperative durvalumab for locally advanced RCC

Moshe Ornstein reports on a phase 1b trial of perioperative durvalumab alone or alongside tremelimumab for the treatment of locally advanced renal cell carcinoma (5:17).

This independent video interview was supported by an educational grant from Pfizer and Merck KGaA

Read transcript

Have your say on Medicine Matters

Visit the conference hub

Image Credits